Michelle Robertson - 11 Jan 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Chief Financial Officer
Signature
/s/ Michelle Robertson
Issuer symbol
EDIT
Transactions as of
11 Jan 2022
Net transactions value
-$44,821
Form type
4
Filing time
13 Jan 2022, 15:17:20 UTC
Previous filing
23 Dec 2021
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $44,821 -1,744 -5.3% $25.70 31,462 11 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 9, 2022. The sale does not represent a discretionary trade by the Reporting Person.